SP Group A/S (CPH:SPG)
404.00
-7.50 (-1.82%)
Nov 20, 2026, 1:21 PM CET
← View all transcripts
Earnings Call: Q3 2024
Nov 15, 2024
Summary
Q3 revenue rose 22% YoY and 9M revenue grew 12.4%, with proprietary products driving growth and margin improvement. FY revenue guidance narrowed to 10%-16%; EBITDA and EBT margin ranges were maintained.
Hi, good afternoon. On behalf of HC Andersen Capital, I would like to welcome you all to this presentation of the Q3 2024 report from SP Group that was published Friday last week. My name is Rasmus Køjborg, and I have the pleasure of welcoming CEO Lars Bering and CFO Tilde Kejlhof. They promise to take us through the numbers here, the highlights from the quarter, and also the expectations for the rest of 2024. Welcome to you two. Before I hand over, I would also like to give a warm welcome to those of you who signed up for today's presentation. You can ask questions in the chat as usual, and if you should have trouble with the slides, viewing the slides here, you might try to refresh your browser, and otherwise, also please write it in the chat if you have any problems in that regards.
We will try to sort it out then. With that, I will leave it to you, Lars and Tilde. Please go ahead.
Thank you very much, and welcome to our Q3 webcast.
Nice that you all will join in.
If there's someone listening in today that does not know SP Group very well, we will start with a short introduction. We are a global manufacturer of plastic solutions, and we are working both as a subcontractor and have our own products. Approximately 70% of our revenue comes from being a subcontractor for demanding industries, and approximately 30% of our revenue comes from our own products. We are having a strategic focus on growth industries, is healthcare, cleantech, and food-related industries. If we take the Q3, then we have been very, very busy. However, I also joined as CEO of SP Group from starting September 1st, and during the past two months, we have had a very good transition period together with former CEO Frank Gad. At the same time, we have had a very nice growth, especially in the sales of our proprietary products at 67%.
In total, the revenue has increased by almost 22%. We have seen EBITDA growth at 55% and EBT growth at 150%. I will also just mention here that we are also comparing with a rather weak Q3 in 2023. If we take the first nine months in total, here it has also been very much the growth in our own brands that has made the picture. 47% in growth in total on the own brands. The total increase in revenue has been 12.4%, and we have realized an EBITDA margin at 20.4% and EBT margin at 11.6%. Finally, we have narrowed down our guidance for the full year revenue. Now we say 10%-16% compared to previously 8%-18%. We maintained our guidance on EBITDA and EBT at 19%-21% EBITDA and 11%-13% EBT.
Looking at the operational highlights for the quarter, we can say that we have had a very good quarter, very good growth, especially in our own brands. To mention a few highlights there, we see that TPI animal housing ventilation products are sold to a greater extent globally. Ergomat has made many good ergonomics projects in both Europe and the U.S., and we have seen an increased demand for medical parts whilst replacing glass. At the same time, we have also been very, very busy establishing our Atlanta factory, and this proceeds as planned. The factory is going to make injection molding and doing assembly tasks, and this is the first time we are able to offer injection molding in the U.S.
We see that the demand locally in the U.S. is driven by customers who would like to de-risk their supply chains, have shorter lead times, and get a better ESG footprint. We expect that production in Atlanta will start before end of the year, and then we will fill up the factory, hopefully during the coming years with new business. Finally, we have increased the amount of electricity produced on our own solar panels. We have produced 43% more in Q3 this year compared to Q3 last year. We have also sold the first mats from Ergomat made in recycled material.
Lars, perhaps a question here on the Atlanta factory. There was a question how much capacity are you adding with the new production facility in the U.S.?
Well, we are adding a potential capacity, because right now we are installing the first handful of machines where we have made agreements with customers to produce locally in the U.S. The factory is approximately 11,000 sq m, and we believe that we can have a number of machines in there.
Just perhaps in terms of the other 30-something factories you have, is this one larger or smaller than these ones, or is this mid-size if you were to compare?
This is-
Yeah.
In the recent years, we have built factories in this size. A couple of years ago, we finalized a factory in Poland at the same size. Four years ago, we made a factory in Tianjin in China, also in the same size. We say, building size, this is a very good size factory for us. We have good expansion possibilities within such a factory. In the case with the Atlanta factory, we have decided to rent out a part of the house to a local distribution company in the beginning, so that we know that it will take time to get it fully utilized. However, it is a time-limited contract, and we hope that we will soon get a need of all the space there.
Okay, very good. Let us jump on with some of the other slides here.
Yeah.
If we look at the key figures, in Q3, we had a growth in revenue on 22%, ended up in DKK 710 million. EBITDA was DKK 145 million, a growth on 55%. EBIT was DKK 93 million, a growth on 120%. Result before tax was DKK 78 million, a growth on 150%. This is a very nice growth rate, but as Lars mentioned earlier, the Q3 in 2023 was not very good. If we look at nine months here in 2024, then we have growth in revenue on 20%, ended up in DKK 2.2 billion. EBITDA was DKK 447 million, a growth on 38%. EBIT was just below DKK 300 million, a growth on 72%. Result before tax was DKK 254 million, which is growth on 83%. Earnings per share was DKK 16.3. We increased the equity by over DKK 200 million to DKK 1.6 billion. If we look at the cash flow, we have a cash flow from operation on above DKK 400 million.
We invested DKK 126 million, and we had cash flow for finance from DKK 245 million, and this also include dividend to shareholders. The debt was DKK 826 million. We had a gearing on 1.5 compared to 2.2 at the same time last year. The equity ratio was 52.5%. If we look at the development in the revenue, the first nine months in 2024, we increased by 12.4%. This is primarily due to strong sales of own products. Historically, we also have grown driven by acquisition and organic growth. The picture in the right corner, that is products from DAN-FENDER to the fisherman industry. If we look at the development in EBITDA, we have an increase on 38% if you compare the nine months compared to 2023. This growth is primarily driven by sales of own products, and then we also utilize our production capacity much better. The orange one is margin.
Here we had 10 years ago a margin on 10%, which we have increased up to 20%. Development in EBT. EBT has increased by 83% in the first nine months in 2024 compared to the same period in 2023. Here we have also increased the margin driven by higher sales in own products and better utilization of production capacity.
If you see the picture down on the right side, it is a typical Ergomat product where it is used in an automotive factory. Here, the operators in the automotive factory are using the symbols in the mat to see how far they should have come with all their tasks while the vehicle is moving along the assembly line. So it is not just a mat, it is also a built-in functionality for the production.
We have talked a lot about own products, and here is some of the own products we are producing. In the top left corner, there are vials from MedicoPack that are used to when you substitute the glass for the plastic vials. You have the guide wires made by SP Medical, and you have the housing animal ventilation made by TPI. Then if you have a nice boat, you can put on some DAN-FENDERs to protect it, and then you have some products used in the fishing industry that are floats and rings. Then, as we saw on the page before, then it is ergonomic mats. To the right, you can see that this increase in sales of own products have increased during the years, and it is now here in the first nine months in 2024, DKK 670 million.
Perhaps a question here on the own brands, because could you elaborate a bit on what is driving this growth? Because I think you are on a record high level now. I think you have bypassed 30% of your revenue, right, in own brands, and the growth has been quite dramatic the recent quarters. So, what is driving this? Is that sort of your own sales force driving it, or is it clients coming back again because they see your product as superior?
In general, there are two things driving this. We have a very, very strong execution in the sales teams. At the same time, we have the factories that are actually supporting and running very well, producing everything that has been sold. This increase in the own products, as you can imagine, also requires or gives high demands to the factories that are producing these products. This is also very well accomplished in these factories because we have never been producing so much of these products before. Looking at our own brands, this is all over. We are selling. We have record sales in the different own brands, not only one, which is very, very good for us.
Also another question related to this, and also what Tilde showed on the previous slides, your earnings has also gone up with quite a large number. As you write in the report, it is related to this sale of own brands. Are there other factors kicking in here also, like your energy cost or the input cost of the different raw material products you use, lower interest rate? What else are kicking in here?
Typically, we have a better margin on our own brands than on being a subcontractor. When you, at the same time, has a record high sale demanding a record high production in these areas, then we are able to utilize the factories to a greater extent than we have done previously here. So, here the factories are running very well, are very, very efficient. That is a part of the increase, and at the same time, selling more with higher earnings is another part.
Good. A last question related to this. There was a question here, what percentage of revenue would you like to see your own brands become longer term?
Well, if you take in the past 10, 15 years, we have increased this own brands coming from 15% up to now 30%. It would be natural to us to try to grow this to an even higher number in the future. If we can continue to grow our own brands a little bit faster than our subcontracting business, then I believe we are also able to increase our margins going forward. It is difficult to set an upper limit. We focus on increasing it a little bit year by year.
Okay, very good. Let us jump on to the different product categories then.
Yeah. If we look at the customer groups and how they have developed, then we have, in the first nine months, sold 40% to the healthcare sector. For us, this has been medical devices, it is medical packaging for MedicoPack, and ergonomic solutions that are providing health and safety. The growth here has been almost 39% in the first nine months, compared to a year last year where we saw a decline. 30% of our sales goes to the cleantech sector. For us, this is plastic components for renewable energy, for energy reduction, and insulation. Here we have seen a growth of 5.6% in the first nine months. Then there is the food-related industries where we have seen a growth on 8.7%, and this is now today 12% of our total sales.
Here it is animal house ventilation, it is measurement equipment, and other plastic components used in the food industry. Then there is other industries, including automotive, which accounts for 18% of the total revenue. This is furniture, special vehicles, marine products, and here we have seen a decline on 13% in the first nine months. We have chosen to have a big exposure towards industries in growth. We see megatrends with a growing aging population, a wish to protect the climate, and therefore we have a strong exposure to these global industries, healthcare, cleantech, and food industries. Our customers, they want fewer and better suppliers, and we have an ambition to be their preferred supplier. Our customers want to reduce complexity, and we help them by offering them to take over their plastic production, leveraging our skills and the economies of scale to provide a customer-specific service.
Our customers, they are always in the market for better and cheaper products. We are helping them to substitute wood, metal, and glass to plastic and composites. We manufacture globally with a powerful team and the right technology. The right technology is actually very important when it comes to plastics. A plastic part can be manufactured in many, many different ways, but choosing the right technology is crucial to get the optimal cost for the part. This is actually where SP Group is making a big difference. We believe that focusing on a number of plastic technologies can help with that. Many plastic producers are only working with one technology, but we have chosen to master all major plastic technologies. Through this, we are able to give the customer the right solution every time. Then we come to the expectations for 2024.
We have throughout the year launched new products, we have gained new customers, and we have sold more to existing customers. Q4 for us is always exciting and challenging. We have a very short order horizon on a big part of our business. We see that some customers will, or we know, some customers most likely postpone a big part of their demand to after Christmas due to warehouse optimization. Other customers would like to have it delivered sooner because they are busy. Therefore, we do not have the full picture yet, but we have narrowed down our expectations for the increase in revenue. Now we say 10%-16%. Previously, we said 8%-18%. We keep our guidance on EBITDA and EBT. EBITDA with a margin of 19%-21%, and EBT on a margin at 11%-13%.
To sum it all up, the growth journey continues and is to a great extent driven by our own products. When we increase the share of own products in the revenue, we are also improving our margins. Typically, we have a lower margin on being a subcontractor than our own products. We have chosen to expand in the U.S. In order to be able to offer injection molding on a global scale, we see a demand in the U.S. that is driven by de-risking supply chain and improving ESG. We are focusing on growth industries, meaning healthcare, cleantech, and food-related industries.
Very good. Thank you very much, Lars and Tilde. There were a few questions, Morten, here that we could come back to. I am just flipping a little bit here in the slides. It was just in regards of the production facility again in Atlanta. There was a follow-up question on the Let me just see if I can find the question here. Just a second. Can you clarify how large capital investments like the Atlanta facility are underwritten in terms of payback period or IRR?
Well, we see that, or we believe that the house itself, here we expect a return on investment on-
Around eight.
Around 8-10. Thereby, we expect around 10 years to have the building paid back. The machines we put in, we normally expect that they are paid back within three years for the specific projects that we are doing there.
Very good. Let me just flip the slides here again on this one, because there was a question related to your debt and your debt compared to the EBITDA in terms of what are your priorities in terms of excess capital? Are you planning to ramp up on acquisitions or buybacks/dividends? There was also a question related to this also. It has been two years since your last acquisitions. Can you give an update on M&A efforts? Will these efforts be given more or less attention with you, Lars, as CEO?
Well, we can start by saying that we are already doing a share buyback program. We started up in August. Regarding the M&A
We have the same interest in M&A as we have always had in SP Group. We are very interested in buying good companies with good management. In the past two years, we have not seen the right candidates where we believe that would fit in SP Group at the right price. We hope to see that in the future. We are still very much interested. As you can see on our debt level now, we also have dry powder to fire with. Yes, we are still interested, but it has to fit in the right way.
Very good. One last question. Do you expect to update your long-term financial ambitions with a new management CEO in place here?
Yes, we expect to do that during the first half of next year.
Okay, very good. We will conclude by that. Thank you very much, Lars and Tilde, for the presentation here today.
Thank you.
Thank you very much, and thank you for listening in.
The same from me here. Thank you to the audience for the questions. We will conclude by that, and I will just wish you all a nice day. Thank you.